Every material Form 8-K Corteva filed with the SEC in 2025, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
Corteva reported third-quarter net sales of $2.62 billion, up 13% from a year earlier, and a GAAP loss from continuing operations of $308 million, narrower than the $519 million loss in the prior-year quarter. The company raised its full-year 2025 guidance, now expecting operating EPS of $3.25 to $3.35 per share and operating EBITDA of $3.8 billion to $3.9 billion. Shareholders will also be watching the planned separation into two independent public companies, expected in the second half of 2026.
Q3 2025 net sales were $2.62 billion, up 13% from $2.33 billion in Q3 2024 (organic sales up 11%).
Q3 2025 GAAP loss from continuing operations after tax was $308 million, versus a $519 million loss in Q3 2024.
Full-year 2025 guidance: net sales $17.7 billion to $17.9 billion, operating EBITDA $3.8 billion to $3.9 billion, operating EPS $3.25 to $3.35 per share.
Company expects to repurchase approximately $1.0 billion of shares in 2025 and plans to separate into two companies in the second half of 2026.
Corteva announced a plan to separate into two independent, publicly traded companies through a tax-free spin-off. The company's current Crop Protection business would form New Corteva, and its Seed business would form SpinCo, with completion expected in the second half of 2026, subject to conditions. The company reaffirmed its full-year 2025 guidance, so the announcement does not change the 2025 outlook it gave shareholders.
New Corteva is estimated to have 2025 net sales of $7.8 billion, or 44% of Corteva's net sales.
SpinCo is estimated to have 2025 net sales of $9.9 billion, or 56% of Corteva's net sales.
The transaction is expected to be completed in the second half of 2026, and Corteva may abandon or change the separation at any time before completion.
Corteva reaffirmed full-year 2025 guidance and will host an investor call on October 1, 2025, at 8:30 a.m. Eastern Daylight Time.
Corteva appointed Jennifer Johnson, formerly general counsel at International Flavors & Fragrances, as chief legal officer effective September 15, 2025. Cornel Fuerer, the current chief legal and public affairs officer, will retire as an executive officer on that date and remain a strategic advisor until 2026. The change is a planned leadership succession and does not include any reported financial results.
Jennifer A. Johnson, age 50, becomes senior vice president, chief legal officer on September 15, 2025
Cornel Fuerer retires as executive officer effective September 15, 2025, and stays on as corporate secretary and public affairs overseer until the end of 2025
Johnson takes over the corporate secretary role and public affairs oversight from Fuerer before the end of 2025
Fuerer serves as strategic advisor until his retirement in 2026, at a time yet to be determined
Corteva reported second-quarter 2025 net sales of $6.46 billion, up 6% from a year earlier, and GAAP earnings per share from continuing operations of $2.02, up from $1.51. The company raised its full-year 2025 guidance, citing a strong first half and expected second-half growth, which points to higher expected earnings for shareholders.
2Q net sales were $6.46 billion, up 6%; GAAP EPS from continuing operations was $2.02 versus $1.51 a year earlier.
2Q operating EPS was $2.20, up 20%, and operating EBITDA was $2.16 billion, up 13%.
Full-year 2025 operating EPS guidance is $3.00 to $3.20; net sales guidance is $17.6 billion to $17.8 billion.
The company expects to repurchase approximately $1 billion of shares during 2025.
Corteva reported first-quarter 2025 results, with net sales down 2% to $4.42 billion while GAAP earnings per share from continuing operations rose to $0.97 from $0.53. The company reaffirmed its full-year 2025 guidance, including net sales of $17.2 to $17.6 billion and operating EPS of $2.70 to $2.95, which matters to shareholders because profit grew faster than sales while the outlook was left unchanged.
Net sales were $4.42 billion, down 2% from $4.49 billion a year earlier; organic sales rose 3%.
GAAP EPS from continuing operations was $0.97 versus $0.53; operating EPS was $1.13, up 27%.
Full-year 2025 guidance reaffirmed: net sales $17.2 to $17.6 billion, operating EBITDA $3.6 to $3.8 billion, operating EPS $2.70 to $2.95.
The company plans to repurchase approximately $1 billion of shares during 2025.
Corteva said director Rebecca Liebert will resign from its Board effective February 28, 2025, and will not stand for re-election at the 2025 Annual Meeting. The company said her decision is not the result of any disagreement with management or the Board, and the Board reduced its size from thirteen to twelve directors.
Rebecca Liebert, Ph.D. notified the Board on February 13, 2025 that she intends to pursue other opportunities.
Her resignation is effective February 28, 2025, and she will not stand for re-election at the 2025 Annual Meeting of Stockholders.
The filing states the resignation is not due to any disagreement with management or the Board on operations, policies, or practices.
The Board reduced its size from thirteen to twelve directors.
Corteva reported fourth-quarter 2024 net sales of $4.0 billion, up 7% from a year earlier, and a GAAP loss from continuing operations of $50 million, smaller than the $231 million loss in the prior-year quarter. For full-year 2024, net sales fell 2% to $16.9 billion and GAAP diluted EPS from continuing operations was $1.22, down from $1.30, while the company refined its 2025 net sales and Operating EPS outlook for currency effects and expects to repurchase about $1 billion of shares in 2025.
Q4 2024 net sales were $3,978 million, up 7%; Q4 GAAP loss from continuing operations was $50 million versus $231 million a year earlier.
Full-year 2024 net sales were $16,908 million, down 2%; GAAP diluted EPS from continuing operations was $1.22 versus $1.30 in 2023.
2025 guidance: net sales of $17.2 billion to $17.6 billion and Operating EPS of $2.70 to $2.95 per share, refined for the stronger U.S. dollar.
The company expects to repurchase approximately $1 billion of shares during 2025 and records approximately $150 million to $165 million in 2025 restructuring charges.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every Corteva filing is on SEC EDGAR ↗. 8-K briefs of other companies →